A Rare Presentation of Fetal Cardiac Rhabdomyoma: Prenatal Diagnosis and Perinatal Management

Main Article Content

Rasna Prasannan
Nina Navakumar
Girija Gurudas
Vidyalekshmy R

Abstract

Fetal cardiac rhabdomyoma is an uncommon benign cardiac tumour and is the most frequently encountered primary cardiac tumour during fetal life. Its prenatal recognition is clinically important because cardiac rhabdomyomas are strongly associated with tuberous sclerosis complex (TSC), particularly when lesions are multiple. We report a 28-year-old primigravida referred at 27 weeks after an echogenic cardiac mass was identified at the routine anomaly scan at 20 weeks. Targeted ultrasonography and fetal echocardiography at 28 weeks demonstrated multiple homogeneous echogenic masses involving both ventricles and the interventricular septum, the largest measuring approximately 2 cm, with mild restriction of left-sided atrioventricular flow. No extracardiac abnormalities or hydrops were identified. The pregnancy was followed with fortnightly surveillance for hydrops, cardiac dysfunction and arrhythmia, with multidisciplinary counselling involving maternal-fetal medicine, neonatology, paediatric cardiology and genetics. Elective caesarean delivery at 38 weeks resulted in a 3-kg male neonate with normal cardiac function and rhythm at birth. Postnatal echocardiography confirmed significant biventricular rhabdomyomas without outflow obstruction. This case highlights the importance of detailed fetal echocardiography, surveillance for haemodynamic compromise, and evaluation for TSC after prenatal detection of cardiac rhabdomyoma. Recent literature supports an expectant approach in haemodynamically stable fetuses, while selected severe cases with progressive obstruction or cardiac compromise may be considered for mTOR-inhibitor therapy in specialist centres.

Downloads

Download data is not yet available.

Article Details

Prasannan, R., Navakumar, N., Gurudas, G., & R, V. (2026). A Rare Presentation of Fetal Cardiac Rhabdomyoma: Prenatal Diagnosis and Perinatal Management. Journal of Cardiovascular Medicine and Cardiology, 94–97. https://doi.org/10.17352/2455-2976.000247
Case Reports

Copyright (c) 2026 Prasannan R, et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Mustafa HJ, Javinani A, Morning ML, D’Antonio F, Pagani G, Puranik PM, et al. Characteristics and outcomes of fetal cardiac rhabdomyoma with or without mTOR inhibitors: a systematic review and meta-analysis. Prenat Diagn. 2024;44(10):1251-67. Available from: https://doi.org/10.1002/pd.6640.

Peng L, Cai Y, Wu J, Ling W, Wu Q, Guo S, et al. Prenatal diagnosis and clinical management of cardiac rhabdomyoma: a single-center study. Front Cardiovasc Med. 2024;11:1340271. Available from: https://doi.org/10.3389/fcvm.2024.1340271.

Northrup H, Aronow ME, Bebin EM, Bissler J, Darling TN, de Vries PJ, et al. Updated international tuberous sclerosis complex diagnostic criteria and surveillance and management recommendations. Pediatr Neurol. 2021;123:50-66.

Bader RS, Chitayat D, Kelly E, Ryan G, Smallhorn JF, Toi A, et al. Fetal rhabdomyoma: prenatal diagnosis, clinical outcome, and incidence of associated tuberous sclerosis complex. J Pediatr. 2003;143(5):620-4. https://doi.org/10.1067/S0022-3476(03)00494-3.

Chao AS, Wang TH, Chang YC, Chang YL, Hsieh CC, Lien R, et al. Outcome of antenatally diagnosed cardiac rhabdomyoma: case series and a meta-analysis. Ultrasound Obstet Gynecol. 2008;31(3):289-95. https://doi.org/10.1002/uog.5264.

Isaacs H Jr. Fetal and neonatal cardiac tumors. Pediatr Cardiol. 2004;25(3):252-73. Available from: https://doi.org/10.1007/s00246-003-0590-4.

Zhou QC, Fan P, Peng QH, D’Amato R, Chen M. Prenatal echocardiographic differential diagnosis of fetal cardiac tumors. Ultrasound Obstet Gynecol. 2004;23(2):165-71.

Rathore B, Adamson ME, Berklite LE, Debnath P, Kline-Fath BM, Miles KG, et al. Fetal cardiac masses. Pediatr Radiol. 2025;55:2400-16. Available from: https://doi.org/10.1007/s00247-025-06431-y.

Milon V, Malinge MC, Blanluet M, Tessarech M, et al. Diagnosis of tuberous sclerosis in the prenatal period: a retrospective study of 240 cases and review of the literature. Eur J Hum Genet. 2024;32(12):1590-8. Available from: https://doi.org/10.1038/s41431-024-01631-w.

Bekiesinska-Figatowska M, Sobieraj P, Pasieczna M, Szymkiewicz-Dangel J. Early diagnosis of tuberous sclerosis complex: prenatal diagnosis. AJNR Am J Neuroradiol. 2023;44(9):1070-6. Available from: https://doi.org/10.3174/ajnr.A7952.

Cavalcante CTMB, Pinto Junior VC, Pompeu RG, Teles ACO, Bandeira JA, Maia ICL, et al. Perinatal unusual rhabdomyoma location: case report and systematic reviews of the literature. J Matern Fetal Neonatal Med. 2021;34(1):137-51. Available from: https://doi.org/10.1080/14767058.2019.1597044.

Martinez-Garcia A, Tirado-Aguilar OA, Acevedo-Gallegos S, Gallardo-Gaona JM, Velazquez-Torres B, Ramirez-Calvo JA, et al. Fetal cardiac rhabdomyomas susceptible to prenatal treatment with mTOR inhibitors: literature review and proposal of a prenatal management algorithm. Front Med (Lausanne). 2025;12:1711774. Available from: https://doi.org/10.3389/fmed.2025.1711774.

Zhao J, Jia P, Zhang Q, Li T, et al. Prenatal ultrasound diagnosis of fetal cardiac rhabdomyoma and analysis of clinical outcomes. Quant Imaging Med Surg. 2026;16(1):36. Available from: https://doi.org/10.21037/qims-2025-1208.

Cai X, Liu J, Zheng W, Jiao Y, Lou Y, Deng M, et al. Prenatal diagnosis of cardiac rhabdomyoma: implications for predicting tuberous sclerosis complex and guiding perinatal management. Ultrasound Obstet Gynecol. 2026;68(1):88-98. Available from: https://doi.org/10.1002/uog.70240